AICAR (50 mg)

(Research Use Only) AICAR (5‑aminoimidazole‑4‑carboxamide ribonucleotide) is a synthetic analog of adenosine monophosphate (AMP) supplied as a lyophilized powder for use as a reference material in laboratory, in‑vitro, and analytical studies conducted by qualified professionals in appropriately equipped research facilities. This product is not a drug and is not intended for human or veterinary use, clinical applications, or any form of in‑vivo administration.

Structural Information AICAR is a monophosphorylated nucleoside analog in which an aminoimidazole‑carboxamide moiety is linked to a ribofuranose phosphate, and it has been described in the research literature as an experimental activator of AMP‑activated protein kinase (AMPK) for studying cellular energy metabolism under controlled conditions.

• Peptide / compound type: Synthetic AMP analog (5‑aminoimidazole‑4‑carboxamide ribonucleotide).

• Molecular formula: C9H15N4O8P.​

• Molecular weight: Approximately 338.22 g/mol.​

• Other designations: 5‑Aminoimidazole‑4‑carboxamide ribonucleotide, AICAR, acadesine.

Intended Use and Limitations This product is supplied for Research Use Only (RUO) and is not intended for human or animal consumption. It must not be used for diagnosis, treatment, cure, or prevention of any disease and must not be compounded, ingested, injected, inhaled, implanted, absorbed, or otherwise administered to humans or animals. Any scientific literature or background information associated with AICAR is provided solely to describe its chemical and research characteristics and should not be interpreted as guidance for clinical use, performance enhancement, metabolic or cardiovascular applications, weight‑management protocols, or other health‑related outcomes.

Handling, Storage, and Quality AICAR should be handled using standard laboratory practices appropriate for nucleoside and small‑molecule reference materials, including suitable personal protective equipment (PPE) and engineering controls to avoid direct contact, inhalation of powders, or environmental release. Unopened lyophilized vials should be stored according to internal laboratory protocols, typically in a cool, dry environment protected from light and moisture to help preserve material integrity prior to use; storage conditions for opened or reconstituted material should be defined and validated by the end user. Each lot may be accompanied by a Certificate of Analysis (COA) providing identity, purity, and analytical data (for example, HPLC and/or mass spectrometry), enabling researchers to document material quality and suitability for their specific experimental applications.

Regulatory and Compliance Notice All products of this type are intended exclusively for research, laboratory, or analytical purposes and are not for human consumption or use in foods, drugs, cosmetics, medical devices, or household chemicals. This material must not be used to create, manufacture, or compound finished dosage forms, and it is not supplied as a prescription medication or active pharmaceutical ingredient